SOW
RPTX

State of Wyoming’s Repare Therapeutics RPTX Stock Holding History

State of Wyoming’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,477
Closed -$53.9K – 1745
2023
Q1 		$53.9K Buy
+5,477
New +$62.8K 0.02% 1089
2022
Q2 		– Sell
-1,079
Closed -$15K – 2092
2022
Q1 		$15K Buy
1,079
+457
+73% +$6.78K 0.01% 1536
2021
Q4 		$13K Buy
622
+110
+21% +$2.59K 0.01% 1639
2021
Q3 		$13K Sell
512
-304
-37% -$9.82K 0.01% 997
2021
Q2 		$25K Buy
816
+495
+154% +$16.2K 0.02% 888
2021
Q1 		$10K Buy
+321
New +$10.9K 0.02% 388

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State of Wyoming's RPTX Position: Q2 2023 in Review

State of Wyoming sold out of Repare Therapeutics (RPTX) in Q2 2023, closing a stake of 5,477 shares — an estimated $53.9K sold.

State of Wyoming first reported a position in RPTX in Q1 2021 and held it in 6 quarters. The position peaked at $53.9K in Q1 2023. 78 funds tracked by Wall St. Rank hold RPTX as of Q2 2023.

  • State of Wyoming reported no remaining Repare Therapeutics position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 5,477 Repare Therapeutics shares in Q2 2023, an estimated $53.9K.
  • State of Wyoming first reported a position in Repare Therapeutics in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Repare Therapeutics position peaked at $53.9K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.